Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain

REFERENCES

• Clarke C, Moore AP. 2005. Parkinson's disease. Clin. Evid. 13:1658–1677.
   Google Scholar
• Fahn S. 2003. Description of Parkinson's disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 991:1–14. http://dx.doi.org/10.1111/j.1749-6632.2003.tb07458.x.
   PubMed Web of Science ®Google Scholar
• Kelley LA, Sternberg MJE. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protoc. 4:363–371. http://dx.doi.org/10.1038/nprot.2009.2.
   PubMed Web of Science ®Google Scholar
• Bosgraaf L, Van Haastert PJ. 2003. Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta 1643:5–10. http://dx.doi.org/10.1016/j.bbamcr.2003.08.008.
   PubMedGoogle Scholar
• Mills RD, Mulhern TD, Cheng H-C, Culvenor JG. 2012. Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations. Biochem. Soc. Trans. 40:1086–1089. http://dx.doi.org/10.1042/BST20120088.
   PubMedGoogle Scholar
• Guo L, Wang W, Chen SG. 2006. Leucine-rich repeat kinase 2: relevance to Parkinson's disease. Int. J. Biochem. Cell Biol. 38:1469–1475. http://dx.doi.org/10.1016/j.biocel.2006.02.009.
   PubMedGoogle Scholar
• Goldwurm S, Zini M, Di Fonzo A, De Gaspari D, Siri C, Simons EJ, van Doeselaar M, Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani C, Meucci N, Sacilotto G, Cilia R, Isaias IU, Bonetti A, Sironi F, Ricca S, Oostra BA, Bonifati V, Pezzoli G. 2006. LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism Relat. Disord. 12:410–419. http://dx.doi.org/10.1016/j.parkreldis.2006.04.001.
   PubMedGoogle Scholar
• Bonifati V. 2006. Parkinson's disease: the LRRK2–G2019S mutation: opening a novel era in Parkinson's disease genetics. Eur. J. Hum. Genet. 14:1061–1062. http://dx.doi.org/10.1038/sj.ejhg.5201695.
   PubMedGoogle Scholar
• Rudenko IN, Kaganovich A, Hauser DN, Beylina A, Chia R, Ding J, Maric D, Jaffe H, Cookson MR. 2012. The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation. Biochem. J. 446:99–111. http://dx.doi.org/10.1042/BJ20120637.
   PubMedGoogle Scholar
• Jorgensen ND, Peng Y, Ho CC-Y, Rideout HJ, Petrey D, Liu P, Dauer WT. 2009. The WD40 domain is required for LRRK2 neurotoxicity. PLoS One 4:e8463. http://dx.doi.org/10.1371/journal.pone.0008463.
   PubMedGoogle Scholar
• Stirnimann CU, Petsalaki E, Russell RB, Müller CW. 2010. WD40 proteins propel cellular networks. Trends Biochem. Sci. 35:565–574. http://dx.doi.org/10.1016/j.tibs.2010.04.003.
   PubMed Web of Science ®Google Scholar
• Smith TF. 2008. Diversity of WD-repeat proteins. Subcell. Biochem. 48:20–30. http://dx.doi.org/10.1007/978-0-387-09595-0_3.
   PubMedGoogle Scholar
• Piccoli G, Condliffe SB, Bauer M, Giesert F, Boldt K, De Astis S, Meixner A, Sarioglu H, Vogt-Weisenhorn DM, Wurst W, Gloeckner CJ, Matteoli M, Sala C, Ueffing M. 2011. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J. Neurosci. 31:2225–2237. http://dx.doi.org/10.1523/JNEUROSCI.3730-10.2011.
   PubMedGoogle Scholar
• Tan E-K. 2006. Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease. Ann. Acad. Med. Singapore 35:840–842.
   PubMed Web of Science ®Google Scholar
• Tan EK, Zhao Y, Skipper L, Tan MG, Di Fonzo A, Sun L, Fook-Chong S, Tang S, Chua E, Yuen Y, Tan L, Pavanni R, Wong MC, Kolatkar P, Lu CS, Bonifati V, Liu JJ. 2007. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum. Genet. 120:857–863. http://dx.doi.org/10.1007/s00439-006-0268-0.
   PubMedGoogle Scholar
• Tan EK, Peng R, Wu YR, Wu RM, Wu-Chou YH, Tan LC, An XK, Chen CM, Fook-Chong S, Lu CS. 2009. LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi-center pooled analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B:1022–1023. http://dx.doi.org/10.1002/ajmg.b.30923.
   PubMedGoogle Scholar
• Brewer GJ, Torricelli JR, Evege EK, Price PJ. 1993. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:567–576. http://dx.doi.org/10.1002/jnr.490350513.
   PubMed Web of Science ®Google Scholar
• Gloeckner CJ, Boldt K, Schumacher A, Ueffing M. 2009. Tandem affinity purification of protein complexes from mammalian cells by the Strep/FLAG (SF)-TAP tag. Proteomics 564:359–372. http://dx.doi.org/10.1007/978-1-60761-157-8_21.
   Google Scholar
• Bourd-Boittin K, Le Pabic H, Bonnier D, L'Helgoualc'h A, Théret N. 2008. RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis. J. Biol. Chem. 283:26000–26009. http://dx.doi.org/10.1074/jbc.M709829200.
   PubMed Web of Science ®Google Scholar
• Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O'Neill E, Meitinger T, Kolch W, Prokisch H, Ueffing M. 2006. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 15:223–232. http://dx.doi.org/10.1093/hmg/ddi439.
   PubMed Web of Science ®Google Scholar
• Xia Z, Dudek H, Miranti CK, Greenberg ME. 1996. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 16:5425–5436.
   PubMed Web of Science ®Google Scholar
• Frangioni JV, Neel BG. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179–187. http://dx.doi.org/10.1006/abio.1993.1170.
   PubMed Web of Science ®Google Scholar
• Huttner WB, Schiebler W, Greengard P, De Camilli P. 1983. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J. Cell Biol. 96:1374–1388.
   Google Scholar
• Messa M, Congia S, Defranchi E, Valtorta F, Fassio A, Onofri F, Benfenati F. 2010. Tyrosine phosphorylation of synapsin I by Src regulates synaptic-vesicle trafficking. J. Cell Sci. 123:2256–2265. http://dx.doi.org/10.1242/jcs.068445.
   PubMedGoogle Scholar
• Gillardon F, Kremmer E, Froehlich T, Ueffing M, Hengerer B, Gloeckner CJ. 2013. ATP-competitive LRRK2 inhibitors interfere with monoclonal antibody binding to the kinase domain of LRRK2 under native conditions. A method to directly monitor the active conformation of LRRK2? J. Neurosci. Methods 214:62–68. http://dx.doi.org/10.1016/j.jneumeth.2012.12.015.
   PubMedGoogle Scholar
• Olsen JV. 2005. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 4:2010–2021. http://dx.doi.org/10.1074/mcp.T500030-MCP200.
   PubMed Web of Science ®Google Scholar
• Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74:5383–5392. http://dx.doi.org/10.1021/ac025747h.
   PubMed Web of Science ®Google Scholar
• Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75:4646–4658. http://dx.doi.org/10.1021/ac0341261.
   PubMed Web of Science ®Google Scholar
• Matteoli M, Takei K, Perin MS, Sudhof TC, De Camilli P. 1992. Exo-endocytotic recycling of synaptic vesicles in developing processes of cultured hippocampal neurons. J. Cell Biol. 117:849–861. http://dx.doi.org/10.1083/jcb.117.4.849.
   PubMedGoogle Scholar
• Piccoli G, Verpelli C, Tonna N, Romorini S, Alessio M, Nairn AC, Bachi A, Sala C. 2007. Proteomic analysis of activity-dependent synaptic plasticity in hippocampal neurons. J. Prot. Res. 6:3203–3215. http://dx.doi.org/10.1021/pr0701308.
   PubMed Web of Science ®Google Scholar
• Ludtke SJ, Baldwin PR, Chiu W. 1999. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128:82–97. http://dx.doi.org/10.1006/jsbi.1999.4174.
   PubMed Web of Science ®Google Scholar
• Berman HM, Bhat TN, Bourne PE, Feng Z, Gilliland G, Weissig H, Westbrook J. 2000. The Protein Data Bank and the challenge of structural genomics. Nat. Struct. Biol. 7(Suppl):957–959. http://dx.doi.org/10.1038/80734.
   PubMedGoogle Scholar
• Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C. 2002. The Protein Data Bank. Acta Crystallogr. D. Biol. Crystallogr. 58:899–907. http://dx.doi.org/10.1107/S0907444902003451.
   PubMed Web of Science ®Google Scholar
• Ullah H, Scappini EL, Moon AF, Williams LV, Armstrong DL, Pedersen LC. 2008. Structure of a signal transduction regulator, RACK1, from Arabidopsis thaliana. Protein Sci. 17:1771–1780. http://dx.doi.org/10.1110/ps.035121.108.
   PubMedGoogle Scholar
• Krieger E, Koraimann G, Vriend G. 2002. Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field. Proteins 47:393–402. http://dx.doi.org/10.1002/prot.10104.
   PubMed Web of Science ®Google Scholar
• Laskowski R, Rullmann JA, MacArthur M, Kaptein R, Thornton J. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8:477–486.
   PubMed Web of Science ®Google Scholar
• Shin N, Jeong H, Kwon J, Heo HY, Kwon JJ, Yun HJ, Kim C-H, Han BS, Tong Y, Shen J, Hatano T, Hattori N, Kim KS, Chang S, Seol W. 2008. LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 314:2055–2065. http://dx.doi.org/10.1016/j.yexcr.2008.02.015.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Coombes CE, Kilaru A, Li X, Gitler AD, Bowers WJ, Dawson VL, Dawson TM, Moore DJ. 2010. GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet. 6:e1000902. http://dx.doi.org/10.1371/journal.pgen.1000902.
   PubMedGoogle Scholar
• Meixner A, Boldt K, Van Troys M, Askenazi M, Gloeckner CJ, Bauer M, Marto JA, Ampe C, Kinkl N, Ueffing M. 2011. A QUICK screen for Lrrk2 interaction partners-leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics. Mol. Cell Proteomics 10:M110.001172. http://dx.doi.org/10.1074/mcp.M110.001172.
   PubMed Web of Science ®Google Scholar
• Sengupta J, Nilsson J, Gursky R, Spahn CMT, Nissen P, Frank J. 2004. Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat. Struct. Mol. Biol. 10:957–962. http://dx.doi.org/10.1038/nsmb822.
   Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C. 2011. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39:D561–D568. http://dx.doi.org/10.1093/nar/gkq973.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. http://dx.doi.org/10.1101/gr.1239303.
   PubMed Web of Science ®Google Scholar
• Skibinski G, Nakamura K, Cookson MR, Finkbeiner S. 2014. Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J. Neurosci. 34:418–433. http://dx.doi.org/10.1523/JNEUROSCI.2712-13.2014.
   PubMed Web of Science ®Google Scholar
• Chernova T, Steinert JR, Guerin CJ, Nicotera P, Forsythe ID, Smith AG. 2007. Neurite degeneration induced by heme deficiency mediated via inhibition of NMDA receptor-dependent extracellular signal-regulated kinase 1/2 activation. J. Neurosci. 27:8475–8485. http://dx.doi.org/10.1523/JNEUROSCI.0792-07.2007.
   PubMedGoogle Scholar
• Gloeckner CJ, Schumacher A, Boldt K, Ueffing M. 2009. The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J. Neurochem. 109:959–968. http://dx.doi.org/10.1111/j.1471-4159.2009.06024.x.
   PubMed Web of Science ®Google Scholar
• West AB, Moore DJ, Choi C, Andrabi SA, Li X, Dikeman D, Biskup S, Zhang Z, Lim KL, Dawson VL, Dawson TM. 2007. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16:223–232. http://dx.doi.org/10.1093/hmg/ddl471.
   PubMed Web of Science ®Google Scholar
• Lee BD, Shin J-H, VanKampen J, Petrucelli L, West AB, Ko HS, Lee Y-I, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, Dawson TM. 2010. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat. Med. 16:998–1000. http://dx.doi.org/10.1038/nm.2199.
   PubMed Web of Science ®Google Scholar
• Kett LR, Boassa D, Ho CC-Y, Rideout HJ, Hu J, Terada M, Ellisman M, Dauer WT. 2012. LRRK2 Parkinson disease mutations enhance its microtubule association. Hum. Mol. Genet. 21:890–899. http://dx.doi.org/10.1093/hmg/ddr526.
   PubMed Web of Science ®Google Scholar
• Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR. 2006. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis. 23:329–341. http://dx.doi.org/10.1016/j.nbd.2006.04.001.
   PubMed Web of Science ®Google Scholar
• Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, Oota E, Lu B. 2008. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 27:2432–2443. http://dx.doi.org/10.1038/emboj.2008.163.
   PubMed Web of Science ®Google Scholar
• Iaccarino C, Crosio C, Vitale C, Sanna G, Carri MT, Barone P. 2007. Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum. Mol. Genet. 16:1319–1326. http://dx.doi.org/10.1093/hmg/ddm080.
   PubMedGoogle Scholar
• Wang Y, Jiang F, Zhuo Z, Wu X-H, Wu Y-D. 2013. A method for WD40 repeat detection and secondary structure prediction. PLoS One 8:e65705. http://dx.doi.org/10.1371/journal.pone.0065705.
   PubMed Web of Science ®Google Scholar
• Ohi MD, Kooi CWV, Rosenberg JA, Ren L, Hirsch JP, Chazin WJ, Walz T, Gould KL. 2005. Structural and functional analysis of essential pre-mRNA splicing factor Prp19p. Mol. Cell. Biol. 25:451–460. http://dx.doi.org/10.1128/MCB.25.1.451-460.2005.
   PubMedGoogle Scholar
• Pryer NK, Salama NR, Schekman R, Kaiser CA. 1993. Cytosolic Sec13p complex is required for vesicle formation from the endoplasmic reticulum in vitro. J. Cell Biol. 120:865–875. http://dx.doi.org/10.1083/jcb.120.4.865.
   PubMedGoogle Scholar
• Vaisman N, Tsouladze A, Robzyk K, Ben-Yehuda S, Kupiec M, Kassir Y. 1995. The role of Saccharomyces cerevisiae Cdc40p in DNA replication and mitotic spindle formation and/or maintenance. Mol. Gen. Genet. 247:123–136. http://dx.doi.org/10.1007/BF00705642.
   PubMedGoogle Scholar
• Wang PI, Marcotte EM. 2010. It's the machine that matters: predicting gene function and phenotype from protein networks. J. Proteomics 73:2277–2289. http://dx.doi.org/10.1016/j.jprot.2010.07.005.
   PubMed Web of Science ®Google Scholar
• Ai E, Skop AR. 2009. Endosomal recycling regulation during cytokinesis. Commun. Integr. Biol. 2:444–447. http://dx.doi.org/10.4161/cib.2.5.8931.
   PubMedGoogle Scholar
• Li X, Patel JC, Wang J, Avshalumov MV, Nicholson C, Buxbaum JD, Elder GA, Rice ME, Yue Z. 2010. Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J. Neurosci. 30:1788–1797. http://dx.doi.org/10.1523/JNEUROSCI.5604-09.2010.
   PubMed Web of Science ®Google Scholar
• Tong Y, Pisani A, Martella G, Karouani M, Yamaguchi H, Pothos EN, Shen J. 2009. R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc. Natl. Acad. Sci. 106:14622–14627. http://dx.doi.org/10.1073/pnas.0906334106.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V, Zhou C, Geghman K, Bogdanov M, Przedborski S, Beal MF, Burke RE, Li C. 2009. Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat. Neurosci. 12:826–828. http://dx.doi.org/10.1038/nn.2349.
   PubMed Web of Science ®Google Scholar
• Sossi V, de la Fuente-Fernández R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, Aasly JO, Farrer MJ, Wszolek ZK, Stoessl JA. 2010. Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov. Disord. 25:2717–2723. http://dx.doi.org/10.1002/mds.23356.
   PubMed Web of Science ®Google Scholar
• Berg D, Schweitzer KJ, Leitner P, Zimprich A, Lichtner P, Belcredi P, Brüssel T, Schulte C, Maass S, Nägele T, Wszolek ZK, Gasser T. 2005. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*. Brain 128:3000–3011. http://dx.doi.org/10.1093/brain/awh666.
   PubMedGoogle Scholar
• Brice A. 2005. Genetics of Parkinson's disease: LRRK2 on the rise. Brain 128:2760–2762. http://dx.doi.org/10.1093/brain/awh676.
   PubMed Web of Science ®Google Scholar
• Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C. 2009. The genetics of Parkinson's syndromes: a critical review. Curr. Opin. Genet. Dev. 19:254–265. http://dx.doi.org/10.1016/j.gde.2009.03.008.
   PubMed Web of Science ®Google Scholar